Home8WK • FRA
add
Abera Bioscience AB
Previous close
€0.66
Day range
€0.53 - €0.61
Year range
€0.28 - €0.78
Avg Volume
4.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 3.57M | 57.44% |
Operating expense | 3.58M | 35.98% |
Net income | 12.00K | 103.34% |
Net profit margin | 0.34 | 102.15% |
Earnings per share | — | — |
EBITDA | 41.00K | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.50M | -17.33% |
Total assets | 11.64M | -0.70% |
Total liabilities | 2.97M | 21.08% |
Total equity | 8.67M | — |
Shares outstanding | 15.35M | — |
Price to book | 1.17 | — |
Return on assets | -0.02% | — |
Return on capital | -0.03% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 12.00K | 103.34% |
Cash from operations | -589.00K | 7.24% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -589.00K | -117.66% |
Free cash flow | -600.62K | -20.03% |
About
Founded
2012
Website
Employees
5
